Outcomes of robotic-assisted radical prostatectomy for patients in two extreme age-groups (< 50 years vs > 65 years)

Authors

  • Radu-Tudor Coman Epidemiology Department, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca
  • Nicolae Crisan Urology Department, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca
  • Iulia Andras Urology Department, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca
  • Gabriela Bud Urology Department, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca
  • Deliu-Victor Matei Division of Urology, European Institute of Oncology, Milan
  • Ottavio de Cobelli Division of Urology, European Institute of Oncology, Milan
  • Ioan Coman Urology Department, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca
  • Ioan-Stelian Bocsan Epidemiology Department, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca

DOI:

https://doi.org/10.15386/cjmed-825

Keywords:

prostate cancer, prostatectomy, robotic surgical procedures, erectile function

Abstract

Background and aims. To assess the outcomes of robotic radical prostatectomy in two different age subgroups of pre-operatively potent patients: younger than 50 years and older than 65 years.

Methods. We included in the present study a number of 202 patients with prostate cancer divided into two groups: 99 patients older than 65 years (group 1) and 103 patients younger than 50 years (group 2).

Results. More than half of the younger patients were low-risk vs 57% of the older patients who were high-risk. Overall positive surgical margins rate was 21.2% in group 1 vs 12.1% in group 2. The early biochemical recurrence at 6 months after radical prostatectomy was 4% in group 1 vs 11.6% in group 2. The continence rate at 6 months was similar between the two groups and was not correlated with the patients’ age (p=0.72), nerve-sparing (p=0.3 for group 1, p=0.92 for group 2) or pathological staging (overall p=0.81, p=0.89 in group 1 and p=0.63 in group 2). We observed a significantly higher rate of potency for patients in group 2 (91.5% vs 47.2%, p<0.0001). The most important factor associated with the regain of potency at 6 months after the procedure was the age of the patient (p<0.0001), independently of the type of nerve-sparing performed.

Conclusions. Age seems to be the most important predictor of the regain of potency after robotic radical prostatectomy. Patients should be counseled accordingly in order to have realistic expectations about the functional results after robotic-assisted surgery.             

Author Biographies

Radu-Tudor Coman, Epidemiology Department, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca

Epidemiology

Iulia Andras, Urology Department, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca

Urology

Gabriela Bud, Urology Department, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca

Urology

Deliu-Victor Matei, Division of Urology, European Institute of Oncology, Milan

Urology

Ottavio de Cobelli, Division of Urology, European Institute of Oncology, Milan

Urology

Ioan Coman, Urology Department, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca

Urology

Ioan-Stelian Bocsan, Epidemiology Department, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca

Epiemiology

Downloads

Published

2018-01-30

How to Cite

1.
Coman R-T, Crisan N, Andras I, Bud G, Matei D-V, de Cobelli O, Coman I, Bocsan I-S. Outcomes of robotic-assisted radical prostatectomy for patients in two extreme age-groups (< 50 years vs > 65 years). Medicine and Pharmacy Reports [Internet]. 2018 Jan. 30 [cited 2025 Jun. 20];91(1):92-7. Available from: https://medpharmareports.com/index.php/mpr/article/view/825

Issue

Section

Original Research